(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP adopt) (NP (CD 3D) (NNP Convolutional) (NNP Neural) (NNP Networks)) (S (VP (TO to) (VP (NN segment) (NP (JJ volumetric) (JJ medical) (NNS images)))))) (. .))
(S (SBAR (IN Although) (S (NP (JJ deep) (JJ neural) (NNS networks)) (VP (VBP have) (VP (VBN been) (VP (VBN proven) (S (VP (TO to) (VP (VB be) (ADJP (RB very) (JJ effective) (PP (IN on) (NP (JJ many) (CD 2D) (NN vision) (NNS tasks)))))))))))) (, ,) (NP (NP (PRP it))) (VP (VBZ is) (ADVP (RB still)) (ADJP (VBG challenging)) (S (VP (TO to) (VP (VB apply) (NP (PRP them)) (PP (TO to) (NP (CD 3D) (NNS tasks)))))) (PP (JJ due) (TO to) (NP (NP (NP (DT the) (JJ limited) (NN amount)) (PP (IN of) (NP (JJ annotated) (CD 3D) (NNS data)))) (CC and) (NP (JJ limited) (JJ computational) (NNS resources))))) (. .))
(S (NP (PRP We)) (VP (VBP propose) (NP (NP (DT a) (JJ novel) (JJ 3D-based) (NN coarse-to-fine) (NN framework)) (SBAR (S (VP (TO to) (VP (ADVP (RB effectively) (CC and) (RB efficiently)) (VB tackle) (NP (DT these) (NNS challenges)))))))) (. .))
(S (NP (DT The) (VBN proposed) (JJ 3D-based) (NN framework)) (VP (VBZ outperforms) (NP (DT the) (CD 2D) (NN counterpart)) (PP (TO to) (NP (DT a) (JJ large) (NN margin))) (SBAR (IN since) (S (NP (PRP it)) (VP (MD can) (VP (VB leverage) (NP (NP (DT the) (JJ rich) (JJ spatial) (JJ infor-) (NN mation)) (PP (IN along) (NP (DT all) (CD three) (NNS axes))))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBP conduct) (NP (NNS experiments)) (PP (IN on) (NP (NP (CD two) (NNS datasets)) (SBAR (WHNP (WDT which)) (S (VP (VBP include) (NP (NP (ADJP (JJ healthy) (CC and) (JJ pathological)) (NNS pancreases)) (ADVP (RB respectively))))))))) (, ,) (CC and) (VP (VBP achieve) (NP (DT the) (JJ current) (NN state-of-the-art)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (NNP Dice-SÃ¸rensen) (NNP Coefficient)) (PRN (-LRB- -LRB-) (NP (NNP DSC)) (-RRB- -RRB-)))))))) (. .))
(S (PP (IN On) (NP (DT the) (NNP NIH) (NNS pancreas) (NN segmentation) (NN dataset))) (, ,) (S (NP (PRP we)) (VP (VBP outperform) (NP (DT the) (JJ previous) (NN best)) (PP (IN by) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (QP (IN over) (CD 2)) (NN %))))))) (, ,) (CC and) (S (NP (DT the) (JJS worst) (NN case)) (VP (VBZ is) (VP (VP (VBN improved) (PP (IN by) (NP (CD 7) (NN %))) (S (VP (TO to) (VP (VB reach) (NP (QP (RB almost) (CD 70)) (NN %)))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ indicates) (NP (NP (DT the) (NN reliability)) (PP (IN of) (NP (PRP$ our) (NN framework))) (PP (IN in) (NP (JJ clinical) (NNS applications)))))))))) (. .))
